Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francesca Torelli
Observed names:
F Torelli,
F. Torelli
Institution:
AOP Orphan (Austria)
Observed institutions:
University of Leeds,
AOP Orphan (Austria)
ORCID:
0009-0000-2177-8186
Observed ORCID:
0009-0000-2177-8186
OpenAlex ID:
A5035241348
Systematic Literature Review of Clinical, Economic, and Humanistic Outcomes Following Minimally Invasive Glaucoma Surgery or Selective Laser Trabeculoplasty for the Treatment of Open-Angle Glaucoma with or Without Cataract Extraction
2023
·
Louis Cantor
, Dan Lindfield
, et al.
·
Clinical ophthalmology
·
32
PDF
The budget impact of introducing the OMNI® surgical system to a United States health plan for managing mild-to-moderate primary open-angle glaucoma
2023
·
Gregory Mader
, Federico Ghinelli
, et al.
·
Expert Review of Pharmacoeconomics & Outcomes Research
·
4
OMNI® surgical system versus iStent inject® with concomitant cataract surgery for the treatment of mild-to-moderate primary open-angle glaucoma in the United States: a cost utility analysis
2023
·
Roberta Longo
, Federico Ghinelli
, et al.
·
Expert Review of Ophthalmology
·
4
Cost-utility analysis of ropeginterferon alfa-2b to manage low-risk patients with polycythemia vera as compared to phlebotomy only in the Austrian healthcare system
2025
·
Evelyn Walter
, Francesca Torelli
, et al.
·
Annals of Hematology
·
3
PDF
HPR195 Assessing the Adoption of Sustainability Criteria Within National Healthcare Procurement Policies in Europe
2022
·
ME Capobianco
, A Qureshi
, et al.
·
Value in Health
·
3
UK General Population Utility Values for the SIDECAR-D Instrument Measuring the Impact of Caring for People With Dementia
2020
·
Edward J.D. Webb
, David Meads
, et al.
·
Value in Health
·
3
PDF
HTA291 How Are Patients Involved in Health Technology Assessment? A Comparative Analysis of European Markets for Advanced Therapies and Implications for Joint Clinical Assessment
2023
·
A. Świder
, A. San Segundo González
, et al.
·
Value in Health
·
2
PDF
EE441 Evaluating the Economic Burden of Polycythemia Vera Across the Disease Continuum: A Systematic Literature Review
2025
·
Surabhi Aggarwal
, Najiya Nahan
, et al.
·
Value in Health
EE628 Economic Benefits of Cangrelor in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Systematic Literature Review
2022
·
E Molchanova
, A Colucciello
, et al.
·
Value in Health
HPR57 Do Favourable Access Conditions and Policies for Biosimilars Result in Increased Consumption in the EU4 and the UK?
2022
·
F Ghinelli
, F Torelli
, et al.
·
Value in Health
PDF
Show more works
View as search
Works count:
10
Citation count:
51
H-index:
3
I10-index:
1
Year
Topic
Type